Innovative AI Solutions Emedgene offers advanced AI-driven platforms for genomic diagnostics and research, positioning it as a valuable partner for healthcare organizations seeking automation and efficiency in genetic data interpretation.
Strategic Industry Partnerships The company's collaboration with Illumina enhances its credibility and market reach, creating opportunities to cross-sell integrated genomic analysis tools to Illumina’s large customer base.
Funding Growth Potential With recent $6 million funding and a focused expansion strategy, Emedgene is scaling its sales operations and product offerings, presenting opportunities to engage with research and clinical labs invest in AI-based genomic solutions.
Target Market Expansion Emedgene is actively expanding its U.S. offices and focusing on genomics-based care, which opens avenues for outreach to health organizations and research institutions looking to adopt scalable AI diagnostics.
Market Differentiation As the pioneer of a fully automated genetic interpretation platform, Emedgene’s innovative products can appeal to geneticists and labs aiming to reduce workload and improve diagnostic turnaround times.
$1B$10B
$50M$100M
$50M$100M
$1M$10M
$10M$25M
$10B
$1B$10B
$25M$50M
$10M$25MEmedgene, an Illumina Company uses 8 technology products and services including Kubernetes, ArangoDB, Modernizr, and more. Explore Emedgene, an Illumina Company's tech stack below.
| Emedgene, an Illumina Company Email Formats | Percentage |
| First@emedgene.com | 44% |
| FirstL@emedgene.com | 6% |
| First@emedgene.com | 44% |
| FirstL@emedgene.com | 6% |
IT Services and IT ConsultingUnited States11-50 Employees
Emedgene is on a mission to unlock genomic insights for the world’s health organizations by providing data-driven AI solutions for genomic diagnostics and discovery at scale. We work with leading healthcare and life sciences organizations to enable precision medicine programs, enable high throughput diagnostics and accelerate the pace of research.
Company Overview
Funding & FinancialsEmedgene, an Illumina Company has raised a total of $6M of funding over 3 rounds. Their latest funding round was raised on Feb 19, 2019 in the amount of $6M.
Emedgene, an Illumina Company's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsEmedgene, an Illumina Company has raised a total of $6M of funding over 3 rounds. Their latest funding round was raised on Feb 19, 2019 in the amount of $6M.
Emedgene, an Illumina Company's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com